Skip to content

Zymeworks ZYME Income Tax

Income Tax at other companies

Pfizer logo
PfizerPFE
$461M+344%
Amgen logo
AmgenAMGN
$265M+9.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$40K-9.1%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$6.37M+13.5%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$0-100%
Septerna, Inc. logo
Septerna, Inc.SEPN
$337K

Other financials

Income statement

See full
Revenue$2.4M-91.1%
Operating income-$47.1M-84.0%
Net income-$44.2M-95.1%
EPS (diluted)-$0.59-96.7%

Balance sheet

See full
Cash & equivalents$244.3M+221%
Total debt$17.0M-7.7%
Total equity$163.6M-49.7%
Total assets$478.2M+12.4%

Cash flow

See full
Operating cash flow-$45.7M-1,242%
CapEx$216.0K+1,250%
Free cash flow-$45.9M-1,242%

Valuation

See full
Market cap$1.76B+125%
Enterprise value$1.53B+112%
P/S21.6×+13.2×

Profitability

See full
Operating margin-140.4%+7.3pp
Net margin-126.3%+5.0pp
FCF margin-94.8%+15.5pp

Returns & leverage

See full
Return on equity-42%+29.2pp
Debt / equity0.1×0.0×
Current ratio10.8×+6.1×

Where this comes from

Reported directly by Zymeworks in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Zymeworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Zymeworks's income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Zymeworks's income tax?
Zymeworks (ZYME) reported income tax of -$2.19M in Q1 2026.
How has Zymeworks's income tax changed year-over-year?
Zymeworks's income tax decreased by 541.7% year-over-year, from $496K to -$2.19M.
What is the long-term trend for Zymeworks's income tax?
Over 2 years (2022 to 2024), Zymeworks's income tax has grown at a -25.3% compound annual growth rate (CAGR), from $10.89M to $6.08M.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.